Fluorescence in situ hybridization to assess transitional changes of aneuploidy for chromosomes 7, 8, 10, 12, 16, X and Y in metastatic prostate cancer following anti-androgen therapy.

International journal of oncology

Volumn 19, Issue 3, 2001, Pages 543-549

  Kasahara, K ^a   Taguchi, T ^a   Yamasaki, I ^a   Karashima, T ^a   Kamada, M ^a   Yuri, K ^a   Shuin, T ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; PROSTATE SPECIFIC ANTIGEN;

ADENOCARCINOMA; AGED; ANEUPLOIDY; ARTICLE; BONE TUMOR; CASE REPORT; CHROMOSOME 16; CHROMOSOME ABERRATION; CHROMOSOME DISORDER; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; HUMAN; HUMAN CHROMOSOME; MALE; METASTASIS; MIDDLE AGED; PATHOLOGY; PROSTATE HYPERTROPHY; PROSTATE TUMOR; SEX CHROMOSOME; X CHROMOSOME; Y CHROMOSOME;

ADENOCARCINOMA; AGED; ANDROGEN ANTAGONISTS; ANEUPLOIDY; BONE NEOPLASMS; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN; CHROMOSOMES, HUMAN, 6-12 AND X; CHROMOSOMES, HUMAN, PAIR 16; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; SEX CHROMOSOMES; X CHROMOSOME; Y CHROMOSOME;

MLCS; MLOWN;

EID: 0035461256     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.19.3.543     Document Type: Article

References (0)